Skip to content
AnalystLens

Fortive Annual Report, Year Ended Dec 31, 2020

Filing Date
Filed February 26, 2021
Period End
December 31, 2020
Security
FTV
In the record · 2016–202610-K1010-Q328-K120

FTV filed 10 annual reports (10-K), 32 quarterly reports (10-Q) and 120 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Oct ’18Oct ’18
  2. Material agreement8-K · Apr ’20Apr ’20
  3. Leadership change8-K · Dec ’22Dec ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 10-K filed February 26, 2021. Cited figures are marked; the original filing is the authoritative source.

Fortive Corporation's 2020 Form 10-K reports total sales of $4.63 billiona in 2020, up 1.5% from $4.56 billion in 2019, with sales from existing businesses declining 5.9% while acquisitions contributed 7.3%.

Operating profit rose to $539.4 millionb from $443.9 million, and operating profit margin was 11.6% versus 9.7% in 2019. Net earnings were $1.61 billion, boosted by a $1.1 billion unrealized gain on Fortive's retained stake in Vontier Corporation. Continuing operations earnings were $1.45 billion, or $4.05 per diluted share, compared with $0.59 in 2019.

The year was defined by the October 9, 2020 separation of the former Industrial Technologies segment through a distribution of 80.1% of Vontier shares to stockholders, with Fortive retaining 19.9%. On January 19, 2021, Fortive exchanged all retained Vontier shares in a non-cash debt-for-equity exchange that reduced indebtedness by $1.1 billionc. Fortive now reports three segments: Intelligent Operating Solutions ($1.88 billion in sales), Precision Technologies ($1.65 billion), and Advanced Healthcare Solutions ($1.10 billion, which includes the Advanced Sterilization Products business acquired from Johnson & Johnson in 2019 for $2.7 billion).

Balance sheet and liquidity remained solid. Cash and equivalents were $1.82 billiond at year-end 2020, long-term debt including current portion was approximately $4.2 billion, and $2.0 billion was available under the Revolving Credit Facility.

Operating cash flow from continuing operations was $977.7 million. Management stated it expects year-over-year global demand to grow at a mid-single digit rate in 2021, and noted that the COVID-19 pandemic remains a material source of uncertainty for the business.

Key Highlights

  1. Total sales of $4,634.4 million in 2020, up 1.5% year over year, with existing businesses down 5.9% and acquisitions adding 7.3%.
  2. Operating profit margin of 11.6% in 2020, an increase of 190 basis points from 9.7% in 2019.
  3. Net earnings of $1,613.3 million included a $1.1 billion unrealized gain on the Retained Vontier Shares; continuing operations diluted EPS was $4.05.
  4. Vontier Separation completed October 9, 2020; the January 19, 2021 debt-for-equity exchange of all retained Vontier shares reduced debt by $1.1 billion.
  5. Cash and equivalents of $1.82 billion at December 31, 2020, with $2.0 billion available under the Revolving Credit Facility and long-term debt of approximately $4.2 billion.
  6. Operating cash flow from continuing operations of $977.7 million in 2020, compared with $702.0 million in 2019.
  7. Recurring revenue represented approximately 40% of total 2020 sales, which management says increased approximately 11% year over year.

Follow one dollar

Of each $1.00 of revenue in FY2020, Fortive kept $0.35.

  1. Revenue$4.63B100.0%
  2. Cost of revenue−$2.03B43.7%
  3. Gross profit$2.61B56.3%
  4. Operating costs−$2.07B44.6%
  5. Operating income$539.4M11.6%
  6. Interest, other & tax$1.07B23.2%
  7. Net income$1.61B34.8%
Computed from 10-KFY2020filed February 26, 2021Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2020 revenue went

$4.63B
  • Cost of revenue: $2.03B, 44% of revenue
  • SG&A: $1.75B, 38% of revenue
  • Operating income: $539.4M, 12% of revenue
  • R&D: $320.7M, 6.9% of revenue

Kept 12% as operating incomeOperating income $539.4M · 12%

Full revenue history →

Financial Statements

FY2020 against FY2019

Line itemFY2020FY2019Change
Revenue$4.63B$4.56B+1.5%
Cost of Revenue$2.03B$2.08B−2.6%
Gross Profit$2.61B$2.48B+5.0%
R&D Expenses$320.70M$320.30M+0.1%
SG&A Expenses$1.75B$1.72B+1.7%
Operating Income$539.40M$443.90M+21.5%
Interest Expense$148.50M$142.60M+4.1%
Net Income$1.61B$738.90M+118.3%
EPS (Basic)$4.58$1.99+130.2%
EPS (Diluted)$4.49$1.97+127.9%
Shares Outstanding (Basic)337.40M335.80M+0.5%
Shares Outstanding (Diluted)359.00M340.00M+5.6%

Frequently Asked Questions

  1. What drove the large jump in 2020 net earnings?

    Net earnings rose to $1,613.3 million from $738.9 million, mainly because of a $1.1 billion unrealized gain on the 19.9% of Vontier common stock Fortive retained after the October 2020 separation. Continuing operations earnings were $1,452.2 million, which also benefited from that gain. Operating profit itself rose to $539.4 million from $443.9 million.

  2. How did the Vontier separation affect Fortive's debt?

    On January 19, 2021, Fortive exchanged all of its retained Vontier shares, 33.5 million shares, for $1.1 billion of its indebtedness held by Goldman Sachs & Co., including all $400 million of the 2021 Term Loan and $683.2 million of the 2020 Delayed-Draw Term Loan. Fortive also repaid the remaining $316.8 million of the 2020 Delayed-Draw Term Loan on January 21, 2021 and repurchased $281 million of its 0.875% Convertible Senior Notes due 2022 on February 9, 2021.

  3. What is the outlook for 2021?

    Management expects year-over-year global demand for its products and services to grow at a mid-single digit rate in both the first quarter of 2021 and the full year 2021. It also said certain businesses, such as SaaS and healthcare businesses with recurring revenue, should remain resilient, while short-cycle industrial businesses continue to face a somewhat challenging environment. Management expects capital expenditures of approximately $75 million to $85 million in 2021.

  4. How exposed is Fortive to international markets and China?

    In 2020, approximately 47% of sales came from customers outside the United States. Sales in China accounted for approximately 12% of total sales, or $534.1 million. The filing notes risks from U.S.-China trade relations, tariffs, and currency movements, and states that a 10% depreciation in major currencies would reduce foreign currency-denominated net assets and stockholders' equity by approximately $185 million.

  5. What was the impact of COVID-19 on 2020 results?

    Sales from existing businesses declined 5.9% in 2020, with the impact most severe in the second quarter, followed by sequential improvement. Management says there was a slight year-over-year increase in demand from existing businesses in the fourth quarter. The company reported it had not experienced a significant impact on its financial position, liquidity, or debt covenant compliance as of the filing date, but described the pandemic's duration and severity as highly uncertain.